Geode Capital Management’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $114K | Sell |
368,720
-241
| -0.1% | -$75 | ﹤0.01% | 4029 |
|
|
2025
Q1 | $155K | Buy |
368,961
+16,613
| +5% | +$6.99K | ﹤0.01% | 3916 |
|
|
2024
Q4 | $247K | Buy |
352,348
+28,705
| +9% | +$20.1K | ﹤0.01% | 3831 |
|
|
2024
Q3 | $152K | Buy |
323,643
+78,876
| +32% | +$37K | ﹤0.01% | 3986 |
|
|
2024
Q2 | $406K | Buy |
244,767
+59,571
| +32% | +$98.9K | ﹤0.01% | 3646 |
|
|
2024
Q1 | $337K | Buy |
185,196
+10,398
| +6% | +$18.9K | ﹤0.01% | 3758 |
|
|
2023
Q4 | $323K | Hold |
174,798
| – | – | ﹤0.01% | 3769 |
|
|
2023
Q3 | $252K | Sell |
174,798
-1,700
| -1% | -$2.45K | ﹤0.01% | 3887 |
|
|
2023
Q2 | $323K | Buy |
176,498
+53,900
| +44% | +$98.6K | ﹤0.01% | 3825 |
|
|
2023
Q1 | $243K | Hold |
122,598
| – | – | ﹤0.01% | 3948 |
|
|
2022
Q4 | $257K | Buy |
122,598
+42,189
| +52% | +$88.4K | ﹤0.01% | 3958 |
|
|
2022
Q3 | $152K | Buy |
80,409
+65,238
| +430% | +$123K | ﹤0.01% | 4356 |
|
|
2022
Q2 | $32K | Buy |
15,171
+1,445
| +11% | +$3.05K | ﹤0.01% | 4859 |
|
|
2022
Q1 | $37K | Buy |
+13,726
| New | +$37K | ﹤0.01% | 4861 |
|